Hydroxychloroquine (HCQS): what it treats and how it's used

Hydroxychloroquine — sold generically as HCQS 200 and HCQS 400 — is one of the most quietly important medicines in rheumatology: the drug lupus patients stay on for decades, and one of the first options for rheumatoid arthritis. Here's what it actually treats, the honest timeline, and the eye-screening rule everyone taking it should know.

What hydroxychloroquine is

Hydroxychloroquine (brand name Plaquenil) began life as an antimalarial and found its real career as a DMARD — a disease-modifying antirheumatic drug. Rather than masking symptoms like a painkiller, it damps the overactive immune signalling that drives autoimmune disease: it accumulates in immune cells, raises the pH of their internal processing compartments, and quiets the toll-like-receptor and antigen-presentation pathways that keep autoimmune inflammation burning. The result is slower, gentler and more fundamental than an anti-inflammatory — which is why it's judged over months, not days.

What it treats

Systemic lupus erythematosus (SLE) is its flagship: hydroxychloroquine is the backbone drug essentially every lupus patient is advised to stay on long-term — it reduces flares, protects organs, improves skin and joint symptoms and measurably improves long-term outcomes. Rheumatoid arthritis: a standard early-line DMARD, alone in milder disease or alongside methotrexate. Other established uses: discoid lupus, some forms of Sjögren's syndrome and certain photosensitive skin conditions. It retains an antimalarial licence, though resistance limits that role today. What it is not: an antiviral, a painkiller, or a drug with any place in self-directed infection treatment.

Dosing and the long game

Standard adult dosing is 200–400mg daily — HCQS 200 once or twice daily, or HCQS 400 as a single dose, taken with food or milk to spare the stomach. The number that matters for safety: no more than 5mg per kg of real body weight per day, the threshold modern retinal-safety guidance is built on. The honest timeline: first signs of benefit around 6–8 weeks, full effect judged at 3–6 months — starting hydroxychloroquine is a commitment to a season, not a fortnight, and stopping early because 'nothing happened by week four' is the most common way it fails.

The eye question, honestly

Hydroxychloroquine's famous risk is retinal toxicity — damage to the macula that, if unchecked, permanently affects central vision. The context that headlines omit: it is rare in the first years at correct doses (well under 1–2% at five years), risk concentrates with high dose, long duration (7+ years), kidney disease and tamoxifen use, and it develops silently — which is exactly why screening exists. UK practice: a baseline eye assessment within the first year, then annual screening from year five (earlier with risk factors). Caught on screening before symptoms, progression usually stops on discontinuation; skipping eye checks is the one genuinely reckless way to take this drug.

Other side effects and interactions

Day to day, hydroxychloroquine is one of the best-tolerated DMARDs: nausea and loose stools early on (food fixes most of it), occasional headache, rash, and — worth knowing — skin pigment changes and vivid dreams with long use. Rarer but real: blood-sugar lowering, muscle weakness with years of use, and QT-interval prolongation — flag any heart-rhythm history and other QT-affecting drugs (some antibiotics, antidepressants and antimalarials) to a clinician. It's generally considered compatible with pregnancy in lupus — one of few DMARDs that is — but that decision always belongs with the treating specialist.

Taking it well

Consistency is nearly everything: same dose, same time, with food, indefinitely — the drug's tissue half-life runs to weeks, so effects build and fade slowly and missed days matter less than abandoned months. Book the eye screening schedule the day you start, weigh-based dose check if your weight changes substantially, and review annually with the prescriber. Buy it like any long-term medicine: sealed blisters, batch numbers, a seller you can identify — and treat any source marketing hydroxychloroquine for infections or 'immune boosting' as the counterfeit-adjacent red flag it is.

Key points to remember

• What hydroxychloroquine is: Hydroxychloroquine (brand name Plaquenil) began life as an antimalarial and found its real career as a DMARD — a disease-modifying antirheumatic drug. Rather than masking symptoms like a painkiller, it damps the overactive immune signalling that drives autoimmune disease: it accumulates in immune cells, raises the pH of their internal processing compartments, and quiets the toll-like-receptor and antigen-presentation pathways that keep autoimmune inflammation burning.
• What it treats: Systemic lupus erythematosus (SLE) is its flagship: hydroxychloroquine is the backbone drug essentially every lupus patient is advised to stay on long-term — it reduces flares, protects organs, improves skin and joint symptoms and measurably improves long-term outcomes. Rheumatoid arthritis: a standard early-line DMARD, alone in milder disease or alongside methotrexate.
• Dosing and the long game: Standard adult dosing is 200–400mg daily — HCQS 200 once or twice daily, or HCQS 400 as a single dose, taken with food or milk to spare the stomach. The number that matters for safety: no more than 5mg per kg of real body weight per day, the threshold modern retinal-safety guidance is built on.
• The eye question, honestly: Hydroxychloroquine's famous risk is retinal toxicity — damage to the macula that, if unchecked, permanently affects central vision. The context that headlines omit: it is rare in the first years at correct doses (well under 1–2% at five years), risk concentrates with high dose, long duration (7+ years), kidney disease and tamoxifen use, and it develops silently — which is exactly why screening exists.
• Other side effects and interactions: Day to day, hydroxychloroquine is one of the best-tolerated DMARDs: nausea and loose stools early on (food fixes most of it), occasional headache, rash, and — worth knowing — skin pigment changes and vivid dreams with long use. Rarer but real: blood-sugar lowering, muscle weakness with years of use, and QT-interval prolongation — flag any heart-rhythm history and other QT-affecting drugs (some antibiotics, antidepressants and antimalarials) to a clinician.
• Taking it well: Consistency is nearly everything: same dose, same time, with food, indefinitely — the drug's tissue half-life runs to weeks, so effects build and fade slowly and missed days matter less than abandoned months. Book the eye screening schedule the day you start, weigh-based dose check if your weight changes substantially, and review annually with the prescriber.

Common questions

What is HCQS 200 used for?

HCQS is generic hydroxychloroquine — the backbone long-term treatment for lupus and a standard early option for rheumatoid arthritis, taken at 200–400mg daily with food. It's a disease-modifier that calms autoimmune inflammation over months, not a painkiller.

How long does hydroxychloroquine take to work?

First improvement typically appears around 6–8 weeks, with the full effect judged at 3–6 months. It modifies the disease process slowly — stopping at week four because nothing has happened yet is the most common mistake.

Does hydroxychloroquine damage your eyes?

Retinal toxicity is real but rare at correct doses, concentrating after 7+ years, at high doses, or with kidney disease. It's silent early — which is why baseline and then annual eye screening from year five is standard, and why skipping eye checks is the one reckless way to take it.

Can I take hydroxychloroquine for an infection?

No — it's not an antiviral or general anti-infective, and self-directed infection use has no evidence behind it. Its legitimate roles are autoimmune disease (lupus, rheumatoid arthritis) and, historically, malaria under medical direction.

References & further reading

• NHS: Hydroxychloroquine — uses, dosage, side effects — official UK guidance.
• Versus Arthritis: Hydroxychloroquine — the UK arthritis charity's patient guide.

This article is general information, not medical advice. Always consult a healthcare professional before starting any medication.